Alzheimer Immunotherapy Trial Grounded: Time to Reassess Safety and Vaccine Design
injecting Aβ1-42 more than two years ago (Schenk et al., 1999), I was very surprised they did it in that
129 RESULTS
You searched Skovronsky et al., 1998
Sort By:
injecting Aβ1-42 more than two years ago (Schenk et al., 1999), I was very surprised they did it in that
subsequent improvement of cognitive function (Qu et al., 2001) reinforces the potential feasibility of HNSC
(Nunomura et al., 2004) showing that where Aβ exists, there is actually less evidence of oxidative stress in
milestone paper by Pratico et al., 2001 on isoprostanes in AD and also papers by Montine et al., 2005 and
the best large population data out there. See Guskiewicz et al., 2005 and Guskiewicz et al., 2007.
appeared in the October-December 2006 supplement. Steve Ferris et al. 0 WEBINAR Monday, March 12, 2007-
inhibitor, which blocks its translocation: dehydroxymethylepoxyquinomicin (Kubota et al., 2007). Lovastatin
neurological disease is the discovery by Hauser et al., recently published in the New England Journal of
IL-1-positive microglia in DS brain of all ages (Griffin et al, 1989). Mqxia: Hi, nice to be back here. June
covered this important milestone with commentary (see Dubois et al., 2007), in the news (see ARF related
et al., (Int. J. Neurosci., 1990, 55:81-88.). Question 3) What percentage of the brains that were
experiment (Wolfe, et al.) are provocative, but they do not conclusively show whether the presenilins are
mitosis[ref.5]). Summary of Paper Under Discussion In the paper being presently discussed, Lu et al. provide data
neurons that light up. Dara Dickstein We have recently published in Microcirculation (Ujiie et al., 2003)
Aβ40 levels whereas only some drove up Aβ42. Kumar-Singh et al. also found that loss of Ab40 correlated
Have a topic idea for a webinar? We would love to hear it. Send an email to webinars [at] alzforum [dot] org.